{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:23:50Z","timestamp":1786994630154,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004610","name":"Science and Technology Support Program of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.nbd.2023.106254","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T01:53:00Z","timestamp":1691373180000},"page":"106254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease"],"prefix":"10.1016","volume":"185","author":[{"given":"Jingru","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.nbd.2023.106254_bb0005","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/mds.25397","article-title":"White matter abnormalities in Parkinson\u2019s disease patients with glucocerebrosidase gene mutations","volume":"28","author":"Agosta","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106254_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104782","article-title":"Genetics of Parkinson\u2019s disease: an introspection of its journey towards precision medicine","volume":"137","author":"Bandres-Ciga","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.nbd.2023.106254_bb0015","first-page":"120","article-title":"A high-resolution in vivo atlas of the human brain\u2019s serotonin system","volume":"37","author":"Beliveau","year":"2017","journal-title":"J. Neurosci."},{"issue":"10291","key":"10.1016\/j.nbd.2023.106254_bb0020","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2023.106254_bb0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cortex.2015.05.022","article-title":"Syntax, action verbs, action semantics, and object semantics in Parkinson\u2019s disease: Dissociability, progression, and executive influences","volume":"69","author":"Bocanegra","year":"2015","journal-title":"Cortex"},{"issue":"2","key":"10.1016\/j.nbd.2023.106254_bb0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","article-title":"Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects","volume":"72","author":"Bohnen","year":"2015","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2023.106254_bb0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","article-title":"[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson\u2019s disease","volume":"62","author":"Booij","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.nbd.2023.106254_bb0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/mds.28818","article-title":"Clinical and dopamine transporter imaging trajectories in a cohort of Parkinson\u2019s disease patients with GBA mutations","volume":"37","author":"Caminiti","year":"2022","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2023.106254_bb0045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/mds.26373","article-title":"Cognition in individuals at risk for Parkinson\u2019s: Parkinson associated risk syndrome (PARS) study findings","volume":"31","author":"Chahine","year":"2016","journal-title":"Mov. Disord."},{"issue":"19","key":"10.1016\/j.nbd.2023.106254_bb0050","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/WNL.0b013e3181fc29c9","article-title":"The MoCA: well-suited screen for cognitive impairment in Parkinson disease","volume":"75","author":"Dalrymple-Alford","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nbd.2023.106254_bb0055","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hbm.25244","article-title":"JuSpace: a tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps","volume":"42","author":"Dukart","year":"2021","journal-title":"Hum. Brain Mapp."},{"issue":"12","key":"10.1016\/j.nbd.2023.106254_bb0060","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.nbd.2023.106254_bb0065","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/mds.29047","article-title":"Neuroimaging in Glucocerebrosidase-associated parkinsonism: a systematic review","volume":"37","author":"Filippi","year":"2022","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.nbd.2023.106254_bb0070","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41380-023-01943-1","article-title":"Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis","volume":"28","author":"Fiore","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106254_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105663","article-title":"Glucocerebrosidase-associated Parkinson disease: pathogenic mechanisms and potential drug treatments","volume":"166","author":"Gegg","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.nbd.2023.106254_bb0080","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.nbd.2023.106254_bb0085","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/mds.28225","article-title":"GBA variants in Parkinson\u2019s disease: clinical, metabolomic, and multimodal neuroimaging phenotypes","volume":"35","author":"Greuel","year":"2020","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.nbd.2023.106254_bb0090","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41593-022-01186-3","article-title":"Mapping neurotransmitter systems to the structural and functional organization of the human neocortex","volume":"25","author":"Hansen","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.nbd.2023.106254_bb0095","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1212\/WNL.0b013e3181d55f61","article-title":"Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo","volume":"74","author":"Klein","year":"2010","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nbd.2023.106254_bb0100","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/ana.25236","article-title":"Serotonin, \u03b2-amyloid, and cognition in Parkinson disease","volume":"83","author":"Kotagal","year":"2018","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2023.106254_bb0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nprot.2015.014","article-title":"A 12-step user guide for analyzing voxel-wise gray matter asymmetries in statistical parametric mapping (SPM)","volume":"10","author":"Kurth","year":"2015","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.nbd.2023.106254_bb0110","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00415-021-10713-4","article-title":"Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive Parkinson\u2019s disease patients","volume":"269","author":"Leocadi","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2023.106254_bb0115","doi-asserted-by":"crossref","first-page":"150.e5","DOI":"10.1016\/j.neurobiolaging.2019.12.023","article-title":"Whole-exome sequencing in early-onset Parkinson\u2019s disease among ethnic Chinese","volume":"90","author":"Li","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.nbd.2023.106254_bb0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s004010100372","article-title":"Choline acetytransferase activity and striatal dopamine receptors in Parkinson\u2019s disease in relation to cognitive impairment","volume":"102","author":"Mattila","year":"2001","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2023.106254_bb0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroimage.2018.11.021","article-title":"The role of dopamine in the brain - lessons learned from Parkinson\u2019s disease","volume":"190","author":"Meder","year":"2019","journal-title":"NeuroImage"},{"issue":"3","key":"10.1016\/j.nbd.2023.106254_bb0130","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1468-1331.2011.03578.x","article-title":"Early-stage cognitive impairment in Parkinson\u2019s disease and the influence of dopamine replacement therapy","volume":"19","author":"Miah","year":"2012","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2023.106254_bb0135","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.nbd.2023.106254_bb0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12883-020-01777-2","article-title":"Extrastriatal (123)I-FP-CIT SPECT impairment in Parkinson\u2019s disease - the PPMI cohort","volume":"20","author":"Nicastro","year":"2020","journal-title":"BMC Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2023.106254_bb0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.5845","article-title":"Association of Dual LRRK2 G2019S and GBA variations with Parkinson disease progression","volume":"4","author":"Ortega","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"10.1016\/j.nbd.2023.106254_bb0150","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/hbm.26206","article-title":"Unravelling neurotransmitters impairment in primary progressive aphasias","volume":"44","author":"Premi","year":"2023","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nbd.2023.106254_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106068","article-title":"Early neurotransmitters changes in prodromal frontotemporal dementia: a GENFI study","volume":"179","author":"Premi","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.nbd.2023.106254_bb0160","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/ene.15230","article-title":"Prevalence and genotype-phenotype correlations of GBA-related Parkinson disease in a large Chinese cohort","volume":"29","author":"Ren","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2023.106254_bb0165","doi-asserted-by":"crossref","first-page":"1091919","DOI":"10.3389\/fnagi.2023.1091919","article-title":"Association of GBA genotype with motor and cognitive decline in Chinese Parkinson\u2019s disease patients","volume":"15","author":"Ren","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2023.106254_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fneur.2020.00047","article-title":"Imaging mild cognitive impairment and dementia in Parkinson\u2019s disease","volume":"11","author":"Sasikumar","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2023.106254_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108822","article-title":"New therapeutic approaches to Parkinson\u2019s disease targeting GBA, LRRK2 and Parkin","volume":"202","author":"Senkevich","year":"2022","journal-title":"Neuropharmacology"},{"issue":"17","key":"10.1016\/j.nbd.2023.106254_bb0180","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.nbd.2023.106254_bb0185","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jnnp-2020-322857","article-title":"Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson\u2019s disease","volume":"91","author":"Stoker","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2023.106254_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102918","article-title":"The correspondence between morphometric MRI and metabolic profile in Rasmussen\u2019s encephalitis","volume":"33","author":"Tang","year":"2022","journal-title":"NeuroImage Clin."},{"issue":"6","key":"10.1016\/j.nbd.2023.106254_bb0195","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10548-018-0653-8","article-title":"Cerebral imaging markers of GBA and LRRK2 related Parkinson\u2019s disease and their first-degree unaffected relatives","volume":"31","author":"Thaler","year":"2018","journal-title":"Brain Topogr."},{"issue":"5","key":"10.1016\/j.nbd.2023.106254_bb0200","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/hbm.25745","article-title":"Dopamine depletion and subcortical dysfunction disrupt cortical synchronization and metastability affecting cognitive function in Parkinson\u2019s disease","volume":"43","author":"Wang","year":"2022","journal-title":"Hum. Brain Mapp."},{"issue":"3","key":"10.1016\/j.nbd.2023.106254_bb0205","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12021-016-9299-4","article-title":"DPABI: Data Processing & Analysis for (Resting-State) Brain Imaging","volume":"14","author":"Yan","year":"2016","journal-title":"Neuroinformatics"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123002693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123002693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:40:24Z","timestamp":1760852424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996123002693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":41,"alternative-id":["S0969996123002693"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106254","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106254"}}